EUVIMEDEUVIMED entdecken
Crossref

Kushenol E alleviates sepsis-associated cognitive dysfunction via microglial indoleamine 2,3-dioxygenase 1 inhibition

Ying Yang, Wenjun Lin, Yifen Zhuo, Jialin Yang, Yuqian Wei, Weidong Pan, Yanling Liao, Yusheng Yao

Phytomedicine · 2026-07 · 157 · 158338

DOI: 10.1016/j.phymed.2026.158338 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Phytomedicine, 2026-07. Verfasst von Ying Yang und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Anesthesiology, Shengli Clinical Medical College of Fujian Medical University, Fujian Provincial Hospital, Fuzhou 350001, China. Hauptthemen laut MEDLINE: Indoleamine-Pyrrole 2,3,-Dioxygenase, Microglia, Cognitive Dysfunction, Sepsis. Die Arbeit nennt 30 Literaturangaben. Gefördert von: Natural Science Foundation of Fujian Province.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND Sepsis-associated encephalopathy (SAE) affects up to 70% of septic patients, but lacks specific therapeutic interventions. Indoleamine 2,3-dioxygenase 1 (IDO1) catalyzes tryptophan degradation via the kynurenine pathway, producing neurotoxic metabolites that drive neuroinflammation. PURPOSE This study investigates whether kushenol E, a prenylated flavonoid from Sophora flavescens, mitigates SAE by inhibiting microglial IDO1. METHODS Sepsis was induced by cecal ligation and puncture (CLP) in male C57BL/6J mice. Cognitive function was assessed by the novel object recognition test and the Morris water maze. Neuronal injury, neuroinflammation, and oxidative stress were evaluated by histology and biochemical assays. IDO1 expression was quantified by quantitative PCR and Western blot, and kynurenine pathway metabolites were profiled by LC-MS/MS. Kushenol E inhibition of murine IDO1 was verified in IFN-γ-stimulated BV-2 microglia. AAV9-mediated F4/80⁺ myeloid-cell-targeted IDO1 overexpression was used as an in vivo rescue strategy. RESULTS CLP induced cognitive impairment, neuronal loss, neuroinflammation, and oxidative stress, accompanied by marked microglial IDO1 upregulation. Kushenol E preserved cognitive function, hippocampal integrity, and synaptic architecture; suppressed neuroinflammation; and limited neurotoxic kynurenine accumulation. Mechanistically, kushenol E inhibited IDO1 catalytic activity without altering its transcript or protein levels. In IFN-γ-stimulated BV-2 microglia, kushenol E suppressed kynurenine production in a concentration-dependent manner (IC50 = 7.38 μM), confirming direct inhibition of murine IDO1. F4/80⁺ myeloid-cell-targeted IDO1 overexpression reversed these protective effects, identifying microglial IDO1 as the principal therapeutic target. CONCLUSION Kushenol E mitigates SAE primarily by inhibiting microglial IDO1 catalytic activity, thereby limiting neurotoxic kynurenine production. These findings nominate microglial IDO1 as a therapeutic target for SAE and support kushenol E as a lead compound for the management of cognitive sequelae in sepsis survivors.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Indoleamine-Pyrrole 2,3,-DioxygenaseMicrogliaCognitive DysfunctionSepsisSepsis-Associated EncephalopathyFlavonoidsAnimalsMaleMice, Inbred C57BLMiceOxidative StressKynurenine

Stichwörter der Autor:innen

Cognitive dysfunctionIndoleamine 2,3-dioxygenase 1Kushenol EKynurenine pathwayMicrogliaSepsis-associated encephalopathy

Substanzen

Indoleamine-Pyrrole 2,3,-DioxygenaseIDO1 protein, mouseKynurenineFlavonoids

Autor:innen und Institutionen

  • Department of Anesthesiology, Shengli Clinical Medical College of Fujian Medical University, Fujian Provincial Hospital, Fuzhou 350001, China.
  • Department of Anesthesiology, Xiamen Haicang Hospital, Xiamen 361026, China.
  • Department of Anesthesiology, Shengli Clinical Medical College of Fujian Medical University, Fujian Provincial Hospital, Fuzhou 350001, China. Electronic address: liaoyanlingfjsl@126.com.
  • Department of Anesthesiology, Shengli Clinical Medical College of Fujian Medical University, Fujian Provincial Hospital, Fuzhou 350001, China. Electronic address: fjslyys@fjmu.edu.cn.

Förderung

  • Natural Science Foundation of Fujian Province

Zitieren

APA

Yang, Y., Lin, W., Zhuo, Y., Yang, J., Wei, Y., Pan, W., Liao, Y., & Yao, Y. (2026). Kushenol E alleviates sepsis-associated cognitive dysfunction via microglial indoleamine 2,3-dioxygenase 1 inhibition. Phytomedicine, 157, 158338. https://doi.org/10.1016/j.phymed.2026.158338

Vancouver

Yang Y, Lin W, Zhuo Y, Yang J, Wei Y, Pan W, et al. Kushenol E alleviates sepsis-associated cognitive dysfunction via microglial indoleamine 2,3-dioxygenase 1 inhibition. Phytomedicine. 2026;157:158338. doi:10.1016/j.phymed.2026.158338

BibTeX
@article{Yang2026,
  author = {Yang, Ying and Lin, Wenjun and Zhuo, Yifen and Yang, Jialin and Wei, Yuqian and Pan, Weidong and Liao, Yanling and Yao, Yusheng},
  title = {Kushenol E alleviates sepsis-associated cognitive dysfunction via microglial indoleamine 2,3-dioxygenase 1 inhibition},
  journal = {Phytomedicine},
  year = {2026},
  volume = {157},
  pages = {158338},
  doi = {10.1016/j.phymed.2026.158338}
}
Kostenlos starten →